1. Home
  2. Analysis
  3. Desflurane
  4. Diarrhea-aggravated

Desflurane and Diarrhea aggravated - a phase IV clinical study of FDA data

Summary:

Diarrhea aggravated is reported as a side effect among people who take Desflurane (desflurane), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Propofol, and have Allergies.

The phase IV clinical study analyzes which people have Diarrhea aggravated when taking Desflurane. It is created by eHealthMe based on reports of 1,270 people who have side effects when taking Desflurane from the FDA, and is updated regularly.

What is Desflurane?

Desflurane has active ingredients of desflurane. eHealthMe is studying from 1,270 Desflurane users. Check the latest studies of Desflurane.

What is Diarrhea aggravated?

Diarrhea aggravated is found to be associated with 3,002 drugs and 1,265 conditions by eHealthMe. Check the latest studies of Diarrhea aggravated.

On Jul, 27, 2026

1,270 people reported to have side effects when taking Desflurane.
Among them, 13 people (1.02%) have Diarrhea aggravated.

Could Desflurane cause Diarrhea aggravated?

Among these 13 people:

How long have people been on Desflurane when they have Diarrhea aggravated? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Diarrhea aggravated when taking Desflurane? *

  • female: 30.77 %
  • male: 69.23 %

What is the age of people who have Diarrhea aggravated when taking Desflurane? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 9.09 %
  • 40-49: 54.55 %
  • 50-59: 18.18 %
  • 60+: 18.18 %

What are other drugs people take besides Desflurane? *

  1. Propofol: 10 people, 76.92%
  2. Fentanyl: 9 people, 69.23%
  3. Ondansetron: 8 people, 61.54%
  4. Lantus: 7 people, 53.85%
  5. Lidocaine: 7 people, 53.85%
  6. Magnesium: 7 people, 53.85%
  7. Percocet: 7 people, 53.85%
  8. Pantoprazole: 7 people, 53.85%
  9. Metoclopramide: 7 people, 53.85%
  10. Cefazolin: 7 people, 53.85%

What are other side effects people have besides Diarrhea aggravated? *

  1. Fatigue (feeling of tiredness): 9 people, 69.23%
  2. Nausea (feeling of having an urge to vomit): 8 people, 61.54%
  3. Rashes (redness): 8 people, 61.54%
  4. Abdominal Distension: 8 people, 61.54%
  5. Acute Kidney Failure: 8 people, 61.54%
  6. Dehydration (dryness resulting from the removal of water): 7 people, 53.85%
  7. Fever: 7 people, 53.85%
  8. Pain: 7 people, 53.85%
  9. Kidney Stones: 7 people, 53.85%
  10. General Physical Health Deterioration (weak health status): 7 people, 53.85%

What are the existing conditions these people have? *

  1. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 7.69%
  2. Diabetes: 1 person, 7.69%
  3. Dermatitis Contact (skin reaction (dermatitis) resulting from exposure to allergens): 1 person, 7.69%
  4. Anaesthesia: 1 person, 7.69%
  5. Allergies: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Desflurane and have Diarrhea aggravated?

- Check whether Diarrhea aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Desflurane:

Diarrhea aggravated treatments and more:

How severe was Diarrhea aggravated and when was it recovered:

Expand to all the drugs that have ingredients of desflurane:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Desflurane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Diarrhea aggravated:

Browse all the conditions that are associated with Diarrhea aggravated:

How the study uses the data?

The study uses data from the FDA. It is based on desflurane (the active ingredients of Desflurane) and Desflurane (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.